Heartland
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)-a pilot study
CONCLUSIONS: Cannabis decoction and cannabis oil showed different pharmacokinetic properties, as well as distinct consequences on patients. This study was performed in a limited number of patients; future studies should be performed to investigate the clinical efficacy in larger populations.

Purpose: The recent release of a medical cannabis strain has given a new impulse for the study of cannabis in Italy. The National Health Service advises to consume medical cannabis by vaporizing, in decoction or oil form. This is the first study that explores the pharmacokinetics and tolerability of a single oral dose of cannabis as decoction (200 ml) or in olive oil (1 ml), as a first step to improve the prescriptive recommendations.
Methods: This is a single-center, open-label, two-period crossover study designed to assess the pharmacokinetics and tolerability of oral cannabis administered to 13 patients with medication overuse headache (MOH). A liquid chromatography tandem-mass spectrometry (LC-MS/MS) method was conducted for the quantification of THC, CBD, 11-OH-THC, THC-COOH, THC-COOH-glucuronide, THCA-A, and CBDA. Blood pressure, heart rate, and a short list of symptoms by numerical rating scale (NRS) were assessed.
Results: Decoctions of cannabis showed high variability in cannabinoids content, compared to cannabis oil. For both preparations, THCA-A and CBDA were the most widely absorbed cannabinoids, while THC and CBD were less absorbed. The most important differences concern the bioavailability of THC, higher in oil (AUC0-24 7.44, 95% CI 5.19, 9.68) than in decoction (AUC0-24 3.34, 95% CI 2.07, 4.60), and the bioavailability of CBDA. No serious adverse events were reported.
Conclusions: Cannabis decoction and cannabis oil showed different pharmacokinetic properties, as well as distinct consequences on patients. This study was performed in a limited number of patients; future studies should be performed to investigate the clinical efficacy in larger populations.
Keywords: Cannabinoids; Cannabis decoction; Cannabis oil; Headache; Oral cannabis; Pharmacokinetics.
-
Uncategorized4 days ago
Halo Collective Announces New Appointment to Board of Directors and Completes Securities Issuance to Independent Consultants, Related Parties, and Suppliers
-
Metal4 days ago
Registration open for IHEA annual meeting
-
Heartland2 days ago
Real Brands Inc. CEO Discusses Corporate Goals and Resolve in Audio Interview with …
-
Heartland6 days ago
CBD Shopping Guide 2021
-
Heartland1 week ago
Debunking Some of the Most Common Misconceptions About Cannabis
-
News7 days ago
CBD News Roundup: Canadian CBD Payment Processor Launches Platform in US
-
Heartland1 week ago
Plus Products Announces Completion of Debentures Conversion Pursuant to Previously Announced Debenture Amendments
-
Heartland1 week ago
How To Confidently Pass Your Drug Test While Using Delta-8 THC